GPER1, a third novel estrogen receptor that binds to estrogen, has recently been found to have elevated expression in lung cancer tissue than in normal lung tissue (4), and to promote proliferation, invasion, and migration of NSCLC cells induced by E2 and its selective agonist G1 (3). The gene discussed is GPER1; the disease is non-small cell lung carcinoma.